Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 8;12(4):56.
doi: 10.1038/s41408-022-00646-0.

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

Léa Sureau  1   2   3 , Caroline Buors  3   4 , Jean-Christophe Ianotto  3   5 , Françoise Boyer  3   6 , Aline Tanguy-Schmidt  2   3   6 , Lydia Roy  7 , Emilie Cayssials  3   8 , Laura Cailly  8 , Jean-Claude Chomel  3   9 , Aurélie Chauveau  10 , Corentin Orvain  2   3   6 , Olivier Mansier  11 , Dana Ranta  12 , Margot Robles  13 , Emmanuel Gyan  3   14 , Olivier Hérault  3   15 , Stanislas Nimubona  3   16 , Tony Marchand  3   16   17 , Eric Lippert  3   4 , Jérémie Riou  18   19 , Valérie Ugo #  20   21   22 , Damien Luque Paz #  23   24   25
Affiliations

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

Léa Sureau et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Worsening at 3 years and long-term prognosis.
A Flow-chart representing the design of the JAKSUIVI study. B Distribution of items for the worsening criteria at 3 years of follow-up. C Kaplan–Meier curve represents overall survival according to the diagnosis (ET: essential thrombocythemia, PV: polycythemia vera) and the worsening status (W+: worsened at 3 years, W−: not worsened). Starting time t0 was the 3 years (3 y) follow-up (FU). D Kaplan–Meier curves for the landmark analysis of overall survival in PV patients. The top plot represented the follow-up of the five first years after the 3-year evaluation and the bottom plot represented the follow-up from 5 to 7 years after the 3-year evaluation with a t0 at 5 years. E Forest plot representing the results of multivariate Cox analysis for overall survival in PV. F Kaplan–Meier curve represents overall survival according to the worsening status in the validation cohort.
See this image and copyright information in PMC

References

    1. Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014;124:2507–13. doi: 10.1182/blood-2014-05-579136. - DOI - PMC - PubMed
    1. Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013;27:1874–81. doi: 10.1038/leu.2013.163. - DOI - PMC - PubMed
    1. Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) Blood. 2012;120:5128–33. doi: 10.1182/blood-2012-07-444067. - DOI - PubMed
    1. Barbui T, Vannucchi AM, Buxhofer-Ausch V, Stefano VD, Betti S, Rambaldi A, et al. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015;5:e369. doi: 10.1038/bcj.2015.94. - DOI - PMC - PubMed
    1. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management. Am J Hematol. 2020;95:1599–613. doi: 10.1002/ajh.26008. - DOI - PubMed